The present studies indicate that both the heterogeneity and functional programs of human T lymphocytes can be distinguished. Within the T4 subset, which is responsible for inducer/helper functions in T-T, T-B and T-macrophage interactions, discrete subpopulations are present; T4 cells bearing the 2H4 molecule (T4+2H4+) induce T8+ suppressor effector cells, and T4 cells bearing the 4B4 molecule (T4+4B4+) induce help for B cell Ig synthesis. Within the T8 subset are precursors and effector cells responsible for both suppressor or cytotoxic function. It is now evident that T4 cells show a preferential interaction with class II MHC determinants on accessory or target cells, whereas T8 cells have a preference for class I determinants. Furthermore, the T4 and T8 glyco proteins themselves may function as associative recognition structures in such functions. Recent work has elucidated the role of the T3-Ti antigen receptor complex which is involved in both antigen recognition and T cell activation. The T3 molecule, a nonpolymorphic determinant is membrane-associated with the 90KD Ti heterodimer, a highly polymorphic structure with both constant and variable regions, making up the T cell receptor for antigen. It is believed that these unique cell surface glycoproteins will have a critical role in regulating the nature and intensity of the immune response. The clinical relevance of these cell surface glycoproteins in human diseases also will be discussed.
Introduction
Accumulating evidence indicates that T lymphocytes play a central role in the immune response by virtue of their ability to specifically recognize antigens, to function as effector cells, and to regulate the nature and intensity of the immune response.
Advancements in our understanding of the T lymphocytes in the last decade have been facilitated by developments in several areas including 1) methods for the identification and characterization of human T lymphocyte subsets; 2) new insights into the structure, organization and function of the T cell receptor and other recognition molecules; 3) role of lymphokines and growth factors in lymphocyte biology; and 4) new approaches to the analysis of autoimmune, immunodeficiency, infections and malignant disorders.
Such studies have provided a large amount of information regarding T cell differentia tion, specificity and the functional programs of the major subpopulation of T lympho cytes as defined by unique cell surface glycoproteins. [1] [2] [3] [4] [5] [6] [7] In this review, we will focus on recent advances in our understanding of the differentiative history of the T lympho cytes and their functional maturation. Furthermore, we will discuss the nature of some recently defined T cell surface molecules which have contributed to our understandings of clinical immunology and the cellular and molecular basis of the immune response. T4+ cells were required for the optimal development of class I specific cytotoxicity by the T8 population15 and they also contained cytotoxic cells against class II bearing target cells.19 As with the generation of T8+ cytotoxic T cells, T4+ cells are required Table 1•@  Evidence  of Heterogeneity  of T4+  Cells for  induction  of  T8+  cytotoxic  T cells,  T4+  cells  are  required  for  induction  of T8+   suppressor  effector  cells  3,20  Antigen-triggered  T4+  cells,  but  not  T8+  cells  produce   a number  of non-specific  helper  factors,  but  dependent  on  the  triggering  stimulus,  either   T4  or  T8  cells  may  secrete  Interleukin  2 Table 2 . The functional role of the 4B4 molecule is now under investiga tion, but the preliminary results show that this molecule may be involved in the inter D. Mechanism of antigen specific T cell activation and growth Antigen specific T cell activation leads to several interrelated cellular events in cluding changes in the expression of surface structures and the secretion of lymphokines. Perturbation of the T3-Ti structures by monoclonal anti-T3 and Ti antibodies conse quently results in the activation of a phosphodiesterase that catalyzes the hydrolysis of the phosphatidylinositol bisphosphate (PIP2) to inositol triphosphate (IP3) and diacyl glycerol (DG).61 IP3 releases Ca2+ from intracellular stores and causes an increase in intracytosolic Ca2+. IP3 is broken down to inositol biphosphate (IP2), inositol phosphate (IP1) and then to inositol. Inositol can be recycled into phosphatidyl inositol (PI) and then converted to PIP2. DG is the putative physiological activator of protein kinase C, an enzyme that has been identified as the receptor for PMA. The combination of an increase in Ca2+ and activated protein kinase C leads to a series of intracellular events which results in the production of Interleukin 2 (IL2). IL2, a soluble factor critical for the clonal expansion of activated T cells, is a 15KD glycoprotein which, once T cells are activated by antigen or mitogen, mediates their proliferation by binding to a highly specific receptor on the T cell surface.67,68 The extent of clonal expansion, and thus the rate and magnitude of the T cell immune response, are directly dependent on IL2 receptor levels and the available concentration of IL2 produced either endo geneously (autocrine regulation) or by a different T cell (endocrine regulation).58,68 The expression of the IL2 receptor is markedly increased by mitogen or antigen binding to the cell or by the binding of anti-T3 or anti-Ti antibodies to the T3-Ti complex. Although IL2 receptor expression can also be induced by anti-T3 or anti-Ti monoclonal antibodies in soluble form, endogeneous production and secretion of IL2 is maximal when the TCR is crosslinked by antigen presented in the context of MHC products or anti-T3 or anti-Ti bound to Sepharose beads.58 Because the TCR complex modulated following receptor triggering by antigen, the reciprocal appearance of T3-Ti and IL2 receptors presumably leaves the cell in a state of responsiveness to either the hormone or antigen ligand. Thus, the transient expression of the IL2 receptors serves to prevent uncontrolled cell growth by cells not specifically stimulated by antigen. In addition, activated T cells, such as IL2 dependent antigen specific T cell clones, express three to four fold greater numbers of either T4 or T8 surface molecules than resting T lymphocytes 69 Such enhanced expression of associative recognition elements may be important in facilitating cell-cell interactions.
II. Clinical relevances of subsets of T cells in human disease
The new insights into T cell heterogeneity and immunoregulation, and into the A. Lymphoproliferative malignancies
As described above, monoclonal antibodies capable of defining T cell surface mole cules have been identified which can discriminate both the differentiative history and functional programs of T cells. Their initial clinical use of antibodies was for diagnostic and descriptive purposes and as a complement to traditional histologic criteria and methods for cellular identification. T cell malignant diseases were known to reflect the same degree of heterogeneity and maturation as is seen in normal T cell ontogeny. The defect of T4 cells in early patients with AIDS results in their inability to recognize and respond to soluble antigen. In contrast, the same population of T4 cells responds normally to mitogen and alloantigen.81 Thus, in contrast to the defects of T4 cells noted in patients with SLE (described below) defects in T4 cells in patients with early AIDS appear to selectively involve the T4+4B4+ subset. Many laboratories have now reported that a major receptor for the human immunodeficiency virus (HIV or HTLV-III/LAV) is the T4 molecule itself and this interaction allows for selective penetration and destruc tion of the inducer population.51,80 The resultant immunologic abnormalities appear to be a consequence of retrovirus infection. The immunologically compromised host is then more susceptible to a broad spectrum of other infectious agents and their sequelae.
C. Autoimmunity
Imbalances in T cell subsets have also been observed with autoimmunity, where a diminution in T8+ suppressor cells leaving unopposed inducer functions is often ob served in association with autoantibody production.
In earlier studies when anti-T4
and anti-T8 monoclonal antibodies were initially defined, we found that SLE patients with multisystem involvement but without renal disease had a high T4/T8 ratio due to a decrease in the number of circulating T8 cells.82 In contrast, patients with SLE manifested by severe renal disease and/or thrombocytopenia had a low ratio of T4/T8 cells.83,84 Nevertheless, many SLE patients had normal T4/T8 ratios. Thus, this ratio alone was insufficient to define a precise defect of the immunoregulatory circuit in these patients. Recent'y, we utilized anti-2H4 antibody to characterize peripheral blood lymphocytes from SLE patients.85 Fig. 1 
